
Taima Organic Bio Launches Premium Arachidonic Acid (ARA) — The Science-Backed Omega-6 Fatty Acid Powering Next-Generation Sports Nutrition
Taima Organic Bio Launches Premium Arachidonic Acid (ARA) — The Science-Backed Omega-6 Fatty Acid Powering Next-Generation Sports Nutrition

What Is Arachidonic Acid? The Science Behind the Muscle-Building Omega-6
Arachidonic Acid (ARA), also known by its IUPAC name (5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoic acid, is a 20-carbon polyunsaturated omega-6 fatty acid (C20H32O2; MW 304.47 g/mol) that plays a pivotal role in human physiology as the primary precursor to eicosanoids — potent signaling molecules including prostaglandins (PGs), thromboxanes (TXs), and leukotrienes (LTs).
Unlike most dietary supplements marketed on theoretical grounds alone, arachidonic acid has been evaluated in multiple human clinical trials involving resistance-trained athletes, demonstrating measurable effects on muscle gene expression, anaerobic capacity, and training adaptation markers.
How Arachidonic Acid Works in Skeletal Muscle
The mechanism of action is rooted in eicosanoid biology:
- Exercise-induced muscle damage triggers phospholipase A2 (PLA2) to release ARA from skeletal muscle membrane phospholipids
- Free ARA is metabolized via COX-2 enzyme into prostaglandins — notably PGE2 and PGF2alpha
- These prostaglandins act as autocrine/paracrine signals that initiate the muscle protein synthesis cascade
- Research confirms that AA supplementation increases myogenic regulatory factor expression (MyoD, myogenin)
- Result: Enhanced satellite cell activation, reduced proteolysis, and accelerated muscle tissue remodeling
Key Clinical Evidence
| Study | Design | Dosage | Duration | Key Findings |
| Roberts et al. (2007)J Int Soc Sports Nutr | RCT, double-blindn=31 males50 days | 1,000 mg/day ARAvs. placebo (corn oil) | +7.1% Wingate peak power;+3.6% avg power;Lower IL-6 at day 25 |
| Markworth et al.(2018) Nutrients | RCT crossovern=19 trained men4 weeks | 1,500 mg/day ARA | Increased MyoD & myogenin mRNA;Reduced inflammatory markers;No systemic inflammation rise |
| Trappe et al.(2002) Am J Physiol | Controlled trialn=24 subjects | AA pathway analysis(post-exercise) | COX inhibition abolished PGF2alpha &muscle protein synthesis post-exercise |
Arachidonic Acid Technical Specifications & Quality Parameters
Taima Organic Bio supplies pharmaceutical-grade Arachidonic Acid produced via advanced microbial fermentation using Mortierella alpina, ensuring consistent purity, traceability, and regulatory compliance. Below are our standard product specifications:
Chemical Identity
| Parameter | Specification |
| Chemical Name | (5Z,8Z,11Z,14Z)-Icosa-5,8,11,14-tetraenoic acid |
| CAS Number | 506-32-1 |
| Molecular Formula | C20H32O2 |
| Molecular Weight | 304.47 g/mol |
| IUPAC Name | (all-Z)-5,8,11,14-Eicosatetraenoic acid |
| Appearance | Pale yellow to golden-yellow clear liquid |
| Form | Oil (liquid) or Powder (microencapsulated) |
| Purity (ARA Content) | >=40% (oil) / >=95% (powder) |
| Source | Microbial fermentation (Mortierella alpina) |
| Solubility | Soluble in ethanol, chloroform; insoluble in water |
Quality Specifications (COA Parameters)
| Test Item | Standard | Method |
| Appearance | Clear yellowish liquid / fine powder | Visual |
| Identification (GC/FAME) | Matches reference standard | USP <621> |
| Assay (Arachidonic Acid) | >=95.0% (powder) / >=40% (oil) | GC-FID |
| Peroxide Value | <=5.0 meq/kg | AOCS Cd 8b-90 |
| Acid Value | <=0.5 mg KOH/g | AOCS Cd 3d-63 |
| Moisture | <=0.5% | Karl Fischer |
| Heavy Metals (as Pb) | <=10 ppm | ICP-MS/AAS |
| Arsenic (As) | <=1 ppm | ICP-MS |
| Lead (Pb) | <=0.1 ppm | ICP-MS |
| Total Plate Count | <=1,000 CFU/g | USP <61> |
| Yeast & Mold | <=100 CFU/g | USP <61> |
| E. coli | Negative/25g | USP <62> |
| Salmonella | Negative/25g | USP <62> |
| Residual Solvents | Complies ICH Q3C | Headspace GC |
Applications of Arachidonic Acid Across Industries
Arachidonic acid’s unique biological properties enable its use across multiple high-growth market segments:
| Application Sector | Use Case | Typical Dosage/Concentration | Target Market |
| Sports Nutrition Supplements | Pre/post-workout capsules for muscle hypertrophy, strength gain, recovery acceleration | 250-1,000 mg per serving (commonly 500-750 mg) | Bodybuilders, powerlifters, athletes 18+ |
| Infant Formula Fortification | Essential brain & visual development nutrient (paired with DHA); mimics breast milk profile | 10-20 mg/100mL formula (1:1 DHA:ARA ratio) | Infant nutrition manufacturers globally |
| Dietary/Nootropic Supplements | Cognitive function, memory support, neurological health ingredient | 200-400 mg/day | Adult wellness, senior health products |
| Cosmetics & Skincare | Skin barrier function, emollient, anti-inflammatory topical formulations | 0.5-2% in creams/serums | Premium anti-aging skincare brands |
| Pharmaceutical R&D | Eicosanoid pathway research, inflammation model compound, drug development substrate | Lab/research grade | Pharma companies, CROs |
| Animal Feed/Pet Nutrition | Growth promotion, immune enhancement, coat health additive | Species-specific dosing | Pet food manufacturers, aquaculture |
Sports Nutrition: The Flagship Application
- Mechanism: ARA -> PLA2 release -> COX-2 conversion -> PGE2/PGF2alpha -> mTOR activation -> muscle protein synthesis
- Clinical validation: Roberts et al. 2007 demonstrated +7.1% peak anaerobic power improvement vs. placebo over 50 days
- Myogenic gene upregulation: MyoD and myogenin mRNA significantly increased (Markworth et al., 2018)
- Safety window: No increase in systemic or intramuscular inflammation markers at studied doses
- Ideal user profile: Resistance-trained individuals with 1+ years experience seeking marginal gains in lean mass and power output
- Synergy note: Works independently from testosterone pathways — suitable for both male and female athletes
Infant Nutrition: The Volume Driver
- ARA is naturally present in human breast milk (~0.4-0.55% of total fatty acids)
- Regulatory status: Approved for infant formula fortification in EU, USA, China, Japan, and 80+ countries
- Global infant formula market: ARA represents ~65% of total commercial ARA demand by volume
- Standard ratio: ARA:DHA at approximately 1:1 or 2:1 depending on regional guidelines
- Production method: Microbial fermentation (Mortierella alpina) is the industry gold standard for infant-grade ARA
Why Choose Taima Organic Bio as Your Arachidonic Acid Supplier?
In a global ARA market projected to reach USD 8.87 billion by 2029 (CAGR 8.5%), selecting the right manufacturing partner determines product quality, supply chain reliability, and competitive advantage. Here’s why industry leaders trust Taima Organic Bio:
Our Core Advantages
- Pharmaceutical-Grade Quality: Every batch manufactured under cGMP-compliant conditions with full ISO 9001:2015, ISO 22000, and HACCP certification
- Microbial Fermentation Expertise: Proprietary Mortierella alpina fermentation technology ensuring consistent ARA content with minimal impurities
- Multi-Purity Options: Available in oil form (>=40% ARA) and microencapsulated powder (>=95% ARA) to suit diverse formulation needs
- Comprehensive Testing: GC-FID identity confirmation, peroxide/acid value control, heavy metal testing (ICP-MS), full microbiological panel
- Flexible Packaging: 1 kg foil bags, 5 kg cartons, 25 kg drums, bulk liquid IBC totes — custom OEM/ODM packaging available
- Competitive MOQ: Starting from just 1 kg for sample/R&D orders, with volume pricing for commercial-scale procurement
- Regulatory Support: Full documentation package including COA, SDS, TDS, DMF-ready dossier, and regulatory consultation
- Global Logistics: Established export channels to North America, EU, Southeast Asia, Middle East, and Latin America markets
- Responsive Service: Dedicated technical team with average quote turnaround under 24 hours; multilingual sales support
- Sustainable Sourcing: Environmentally responsible production practices aligned with ESG principles and green chemistry standards
Quality Assurance Commitment
| QA/QC Dimension | Taima Standard |
| Manufacturing Standard | cGMP, ISO 9001:2015, ISO 22000, HACCP certified facility |
| Identity Confirmation | GC-FID fatty acid methyl ester (FAME) profiling |
| Purity Verification | HPLC/GC quantitative assay against USP reference standard |
| Heavy Metal Control | ICP-MS meeting USP <232>/<233> elemental limits |
| Microbiological Safety | USP <61>/<62> compliant; pathogens absent |
| Stability Program | ICH Q1A(R2) long-term + accelerated stability data |
| Traceability | Full lot genealogy from strain bank to finished product |
| Documentation | COA, TDS, SDS, DMF support, audit-ready records |
| Shelf Life | 24 months (proper storage: cool, dark, nitrogen-flushed) |